216 related articles for article (PubMed ID: 12436372)
1. [Gastrointestinal side effects in the therapy of rheumatologic diseases].
Schiemann U; Kellner H
Z Gastroenterol; 2002 Nov; 40(11):937-43. PubMed ID: 12436372
[TBL] [Abstract][Full Text] [Related]
2. Advances in the medical management of rheumatoid arthritis.
Scott DL
Hosp Med; 2002 May; 63(5):294-7. PubMed ID: 12066349
[TBL] [Abstract][Full Text] [Related]
3. Progress in the treatment of rheumatoid arthritis.
Pisetsky DS; St Clair EW
JAMA; 2001 Dec; 286(22):2787-90. PubMed ID: 11735734
[No Abstract] [Full Text] [Related]
4. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
Geborek P; Crnkic M; Petersson IF; Saxne T;
Ann Rheum Dis; 2002 Sep; 61(9):793-8. PubMed ID: 12176803
[TBL] [Abstract][Full Text] [Related]
5. Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
Kremer JM
Ann Intern Med; 2001 Apr; 134(8):695-706. PubMed ID: 11304108
[TBL] [Abstract][Full Text] [Related]
6. [Biologicals in the treatment of rheumatic diseases].
Scherer HU; Burmester GR
Dtsch Med Wochenschr; 2006 Oct; 131(41):2279-85. PubMed ID: 17036270
[No Abstract] [Full Text] [Related]
7. [Effective combination therapy of TNF antagonists with DMARDs].
Ohtsubo H; Matsuda T
Nihon Rinsho; 2007 Jul; 65(7):1287-91. PubMed ID: 17642245
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
[TBL] [Abstract][Full Text] [Related]
9. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
10. Therapies for active rheumatoid arthritis after methotrexate failure.
O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
[TBL] [Abstract][Full Text] [Related]
11. [62nd Congress of the American College of Rheumatology, San Diego, 8-12 November 1998].
Cherin P
Rev Med Interne; 1999 Apr; 20(4):311-7. PubMed ID: 10327473
[No Abstract] [Full Text] [Related]
12. Current treatment of juvenile rheumatoid arthritis.
Ilowite NT
Pediatrics; 2002 Jan; 109(1):109-15. PubMed ID: 11773549
[TBL] [Abstract][Full Text] [Related]
13. [New drugs and treatment strategies for rheumatoid arthritis].
Fantini F
Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapies in rheumatologic disorders.
Miller AV; Ranatunga SK
Med Clin North Am; 2012 May; 96(3):475-96, ix-x. PubMed ID: 22703852
[TBL] [Abstract][Full Text] [Related]
15. [2 years data of controlled trials with leflunomide vs. methotrexate and leflunomide vs. sulfasalazine].
Krüger K
Z Rheumatol; 2002 Jun; 61(3):308-10. PubMed ID: 12219638
[No Abstract] [Full Text] [Related]
16. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
Gaudin P
Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291
[No Abstract] [Full Text] [Related]
17. Anti-tumor necrosis factor therapies.
Taylor PC
Curr Opin Rheumatol; 2001 May; 13(3):164-9. PubMed ID: 11333343
[TBL] [Abstract][Full Text] [Related]
18. [Adverse events in rheumatoid arthritis patient with etanercept therapy: the appearance of osteomalacia].
D'Amore M; Minenna G; D'Amore S
Recenti Prog Med; 2005 Nov; 96(11):552-5. PubMed ID: 16499162
[TBL] [Abstract][Full Text] [Related]
19. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
[TBL] [Abstract][Full Text] [Related]
20. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
Williams VL; Cohen PR
Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
